对于肠道高氧化尿的临床试验的终点考虑
Craig B Langman1, Dean Assimos2, Melanie Blank3
1Feinberg School of Medicine, Department of Pediatrics, Northwestern University, Chicago, Illinois.
肠道高氧化尿,导致结石和功能衰竭,缺乏FDA批准的治疗方法. 这项研究审查了潜在的临床试验终点,但发现了数据缺口,延迟了对新疗法的最终建议.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 胃肠病学 胃肠病学
- 临床试验设计 临床试验设计
背景情况:
- 肠道高氧化尿症涉及氧酸盐吸收增加,导致结石和慢性病 (CKD).
- 目前的治疗方法有限,评估新疗法的有效临床试验终点尚未确定.
- 没有美国食品和药物管理局批准的治疗方法用于肠道高氧化尿.
研究的目的:
- 审查关于肠道高氧化尿的临床试验中潜在终点的证据.
- 确定和评估用于评估治疗疗效的替代终点.
主要方法:
- 一个多学科的健康倡议工作组召开了会议,审查现有数据.
- 支持潜在临床和代用终点的证据得到了批判性评估.
主要成果:
- 潜在的临床结果:症状性结石事件.
- 确定了潜在的代用终点:功能丧失,无症状的结石变化,尿氧酸/氧酸过和血氧酸.
- 数据缺口阻止了对临床试验终点的最终建议.
结论:
- 需要进一步的研究,以确定肠道高氧化临床试验的可靠终点.
- 有信息的试验设计和医疗产品开发需要更多的数据.
- 这项研究强调了需要验证的代用终点来加速治疗进展的必要性.
更多相关视频
07:45Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
09:40Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
相关概念视频
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Chronic Kidney Disease II: Clinical Manifestations
